RT @AnnSurgOncol: MARCH ISSUE: Long-Term Follow-Up of #DesmoidFibromatosis Treated with PF-03084014, an Oral Gamma Secretase Inhibitor. ht…
RT @AnnSurgOncol: MARCH ISSUE: Long-Term Follow-Up of #DesmoidFibromatosis Treated with PF-03084014, an Oral Gamma Secretase Inhibitor. ht…
RT @AnnSurgOncol: MARCH ISSUE: Long-Term Follow-Up of #DesmoidFibromatosis Treated with PF-03084014, an Oral Gamma Secretase Inhibitor. ht…
RT @AnnSurgOncol: MARCH ISSUE: Long-Term Follow-Up of #DesmoidFibromatosis Treated with PF-03084014, an Oral Gamma Secretase Inhibitor. ht…
RT @AnnSurgOncol: MARCH ISSUE: Long-Term Follow-Up of #DesmoidFibromatosis Treated with PF-03084014, an Oral Gamma Secretase Inhibitor. ht…
RT @AnnSurgOncol: MARCH ISSUE: Long-Term Follow-Up of #DesmoidFibromatosis Treated with PF-03084014, an Oral Gamma Secretase Inhibitor. ht…
RT @AnnSurgOncol: MARCH ISSUE: Long-Term Follow-Up of #DesmoidFibromatosis Treated with PF-03084014, an Oral Gamma Secretase Inhibitor. ht…
MARCH ISSUE: Long-Term Follow-Up of #DesmoidFibromatosis Treated with PF-03084014, an Oral Gamma Secretase Inhibitor. https://t.co/4RngAPF17U
Long-Term Follow-Up of Desmoid Fibromatosis Treated with PF-03084014, an Oral Gamma Secretase Inhibitor.:… https://t.co/IdzgeQSfWH #Wnt